论文部分内容阅读
白血病是国内十大高发恶性肿瘤之一,其恶性程度高,进展快,预后差。目前尚无特异性治疗方法,化疗能有效缓解症状,延长生存期,但存在“敌我不分”的情况,常引起较大的不良反应且耐药现象时有发生。靶向药物如伊马替尼治疗BCR/ABL融合基因阳性的慢性粒细胞白血病有显效,但尚无证据显示其可缩短患者发展至加速期的时间,且昂贵的价格给病患家庭和社会带来沉重的负担,故寻找新的更有效的治疗方法和药物已成为当前白血病治疗研究的当务之急。近年来,中医药在治疗白血病方面取得了显著的疗效,相关机制研究也取得了很大进展,涌现出大量有关中
Leukemia is one of the top 10 high-grade malignant tumors in China with high malignant degree, rapid progression and poor prognosis. At present there is no specific treatment, chemotherapy can effectively relieve symptoms and prolong survival, but there are “enemies and I do not divide ” situation, often cause greater adverse reactions and drug resistance have occurred. Targeted drugs such as imatinib treatment of BCR / ABL fusion gene positive chronic myeloid leukemia has been effective, but there is no evidence that it can shorten the patient’s development to accelerate the period of time, and expensive prices to patients with family and social belt To heavy burden, so looking for new and more effective treatment methods and drugs has become the current priority leukemia treatment research. In recent years, Chinese medicine in the treatment of leukemia has made significant effect, the relevant mechanism research has made great progress, emerged in a large number of related